Jon Jones has signed his first endorsement deal since his UFC reinstatement, hours after Reebok confirmed it would not renew its agreement with the fighter. The new sponsor remains unnamed. The deal closes a three-month gap during which Jones fought without individual apparel backing, relying instead on the UFC's broader Reebok partnership that pays fighters based on bout count and rank.

Reebok's exit was procedural rather than punitive. The brand's UFC fighter roster contracts include morals clauses tied to active suspensions, not reinstatements. Jones's 15-month suspension for a failed drug test expired in October; Reebok's deal expired 30 days later. The company declined to negotiate a renewal, according to two people familiar with the decision. Jones's management at Malki Kawa's First Round Management began outreach to six brands in early November, pitching a fighter with 27 professional wins, 15 title defenses across two weight classes, and a Q Score that ranks in the bottom quartile among active UFC champions due to repeated infractions.

The unnamed sponsor matters more for what it prices than what it pays. Jones's team structured the deal without public disclosure requirements, avoiding the revenue reporting that would set a floor for future athletes negotiating post-suspension. This approach mirrors the 2019 playbook used by Conor McGregor's team after his own legal troubles, when he signed with Roots of Fight and Proper No. Twelve whiskey without announcing terms. McGregor's deals later leaked at $5 million and $600,000 respectively, but only after he had secured a higher-value agreement with DraftKings. The sequencing let him avoid anchoring.

For brands, the calculus is inverse. Signing Jones now means acquiring him at a discount to his 2016 peak, when he earned an estimated $8 million annually from Nike, Gatorade, and MuscleTech before his first suspension. His current asking price is believed to be 60-70% below that figure, according to one sponsorship advisor who reviewed the terms but was not authorized to discuss them. The risk is reputational; the reward is access to a fighter whose next bout will likely draw 1.2 million pay-per-view buys based on his pre-suspension average, and whose Instagram following has grown 18% during his time away to 6.8 million.

The deal also shifts leverage in UFC fighter negotiations. Under the Reebok partnership, which pays fighters between $3,500 and $40,000 per fight depending on tenure, athletes cannot wear competing brands in the octagon. But they can sign personal endorsements for non-apparel categories and appearances outside events. Jones's new sponsor is reportedly in the supplement or beverage category, leaving apparel open. If the partnership performs, it sets a template for other suspended fighters to monetize reinstatement windows before their next violation or retirement.

Three other UFC fighters are currently negotiating post-suspension deals: a welterweight whose manager confirmed outreach to four energy drink brands, a featherweight in discussions with a CBD company, and a heavyweight whose team is pitching him to automotive sponsors. None have closed. Jones's deal, even unnamed, gives them a reference point. It also gives the UFC a problem. If individual fighter sponsorships begin outearning Reebok's fixed payments, the promotion's $70 million annual apparel deal looks less like exclusive access and more like a cap on athlete income.

What to watch: Jones's next fight announcement, expected by late January, will determine whether the sponsor reveals itself via in-cage branding or stays off apparel entirely. His opponent will matter; a bout against Stipe Miocic or Francis Ngannou would likely trigger higher activation budgets. Separately, Reebok's UFC deal expires in March 2021, and the company has not yet begun renewal talks. If Jones's unnamed sponsor is a Reebok competitor, expect it to surface in those negotiations as a case study for why the exclusivity model no longer holds.

The sponsor signed a fighter three suspensions deep. The question is whether they bought low or just bought risk at full price.